 |
ProteoMediX
Founders: Christian Brühlmann and Ralph Schiess
Switzerland | Funding: $21.3M (+)
Website: http://www.proteomedix.com
ProteoMediX is specialized in the identification of novel biomarkers for the early detection of cancer. The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard.
Website: http://www.proteomedix.com
ProteoMediX is specialized in the identification of novel biomarkers for the early detection of cancer. The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard.
